RT | June 10, 2021 Three scientists from a FDA advisory committee have resigned after the US food and drug regulator rammed through the approval of a controversial drug to treat Alzheimer’s disease in the face of near-unanimous opposition. Ten out of 11 members of the Peripheral and Central Nervous System Advisory Committee voted against […]
Source